1. COVID-19 threatens M&A already in process— Physician survey shows widespread concern about access to testing and medical supplies for COVID— Novartis cancels $1B generics sale — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Bydureon - Here is the truth

Discussion in 'Amylin' started by Anonymous, Jan 27, 2012 at 5:26 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Are you kiddin' me? Drs will push this system because they will get to bill for those small surgeries.
     

  2. anonymous

    anonymous Guest

    Nice try. Nausea was 2% in the studies. This product is a game changer and you dont even know yet what minor surgery procedure will cost. Patients will want it and so will primary care docs so they can control compliance. Managed care will love too because a compliant patient doesnt go to hospital. 1 hospital admission saved pays for.hundreds of patients to get product. Its a no brainer.
     
  3. anonymous

    anonymous Guest

    The time of launch is NEVER...sorry.
     
  4. My sources say NO...what are smoking. Plus increase risk for pancreatic cancer, all for ~1.2 A1c drop get real numnuts!